Atypical Chemokine Receptor 4 (ACKR4) in Anti-tumor Immu

Project: Research project

Description

Atypical Chemokine Receptor 4 (ACKR4) in Anti-tumor Immunity in colorectal cancer
StatusActive
Effective start/end date8/1/177/31/19

Funding

  • NIH NATIONAL CANCER INSTITUTE (NCI)

Fingerprint

Chemokine Receptors
Colorectal Neoplasms
Immunity
Neoplasms